Westport, CT-based diagnostics startup 3PrimiR has raised $2.1 million of a proposed $4 million round of equity financing, according to an SEC filing. Yale scientists launched the startup based on their research that involves how mutations in micro RNA molecules can be used in cancer diagnostics, according to the Yale University Office of Cooperative Research website. The scientists listed as founders of the company on the Web were not immediately available for comment this morning. The SEC filing did not name the investors in the round.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
